🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Dolutegravir is a potent integrase strand transfer inhibitor. Abacavir/dolu...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-06-06
Trial ID
NCT03016533
The aim of this cross-over study is to compare the relative bioavailability...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-05-03
Trial ID
NCT03095638
Dolutegravir (DTG) is an HIV drug in the integrase inhibitor drug class. Th...
Status
Completed
Location
University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program (Site ID: 4601)
Start Date
2011-04-20
Trial ID
NCT01302847
This is a 2-part, single-dose, open label, randomized 3-way cross-over stud...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-02-26
Trial ID
NCT03441984
Treatments Being Tested
The purpose of this study was to evaluate the safety, tolerability, and pha...
Status
Completed
Location
USC - Maternal Child Adolescent/Adult Center
Start Date
2022-10-05
Trial ID
NCT05406583
This is an open-label, randomized, crossover study in healthy adult subject...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-09-01
Trial ID
NCT02893488
Treatments Being Tested
The rationale for this study is to evaluate and understand the variability ...
Status
Completed
Location
Altasciences
Start Date
2021-08-01
Trial ID
NCT05030025
This study will assess the effect of food on the pharmacokinetics (PK) of p...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-05-07
Trial ID
NCT04827134
This relative bioavailability (RBA) study will be conducted to investigate ...
Status
Completed
Location
RTCCS Radboudumc
Start Date
2022-10-06
Trial ID
NCT05489406
Treatments Being Tested
The purpose of this study was to examine the pharmacokinetics, safety, and ...
Status
Completed
Location
David Geffen School of Medicine at UCLA NICHD CRS
Start Date
2020-09-09
Trial ID
NCT03760458